Biomarkers in the Diagnosis of Acute Compartment Syndrome

NCT ID: NCT04674592

Last Updated: 2022-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-05

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective multinational, multicentre cohort study aims to investigate the hypothesis that biomarkers of muscle cell damage can predict acute compartment syndrome in patients with tibial fractures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with a tibial fracture are included. P-myoglobin and P-creatine phosphokinase are analysed at 6-hourly intervals pre- and if applicable, postoperatively after surgical fixation or fasciotomy. Also, blood samples will be collected in 6 hourly intervals if acute compartment syndrome is suspected. An expert panel of senior orthopaedic surgeons will retrospectively assess study data and classify patients who had undergone fasciotomy into those with and without acute compartment syndrome.

Blood samples will also be collected in patients with acute compartment syndrome without tibial fractures, to serve as a positive control group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Compartment Syndrome Tibia Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tibial fracture

Patients with a traumatic tibial fracture and without acute compartment syndrome.

Blood samples and biopsies

Intervention Type OTHER

Blood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.

Tibial fracture complicated by acute compartment syndrome

Patients with a tibial fracture and acute compartment syndrome of fractured leg.

Blood samples and biopsies

Intervention Type OTHER

Blood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.

Acute compartment syndrome without fracture

Patients with acute compartment syndrome but without a fracture.

Blood samples and biopsies

Intervention Type OTHER

Blood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood samples and biopsies

Blood samples for analysis of biomarkers of muscle damage. Muscle biopsies for histological analysis of muscle damage.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Traumatic tibial fracture


\- Suspected acute compartment syndrome

Exclusion Criteria

* Malignancy
* Acute myocardial infarction
* Kidney failure (GFR ≤35 ml/min)
* Muscle disease
* Paraplegia/tetraplegia

Non-fracture group


* Malignancy
* Acute myocardial infarction
* Kidney failure (GFR ≤35 ml/min)
* Muscle disease
* Paraplegia/tetraplegia
* Associated fracture
* Acute vascular event
Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical Research Council of Southeast Sweden

OTHER_GOV

Sponsor Role collaborator

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

University Hospital, Linkoeping

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jörg Schilcher

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jörg Schilcher, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Linkoeping

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University hospital of Linkoping

Linköping, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jörg Schilcher, MD, PhD

Role: CONTACT

+46101030000

Abraham Nilsson, MD

Role: CONTACT

+46101030000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jörg Schilcher, MD, PhD

Role: primary

+46101030000

References

Explore related publications, articles, or registry entries linked to this study.

Nilsson A, Ibounig T, Lyth J, Alkner B, von Walden F, Fornander L, Ramo L, Schmidt A, Schilcher J. BioFACTS: biomarkers of rhabdomyolysis in the diagnosis of acute compartment syndrome - protocol for a prospective multinational, multicentre study involving patients with tibial fractures. BMJ Open. 2022 May 2;12(5):e059918. doi: 10.1136/bmjopen-2021-059918.

Reference Type DERIVED
PMID: 35501102 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BioFACTS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hematoma Block Versus Bier Block for Closed Fracture Reduction
NCT05086224 ACTIVE_NOT_RECRUITING EARLY_PHASE1